Skip to content

Inventories at other companies

Pfizer logo
PfizerPFE
$2.46B-11.9%
Merck & Co. logo
Merck & Co.MRK
$6.2B+36.0%
AbbVie logo
AbbVieABBV
$5.05B+11.6%
Insmed logo
InsmedINSM
$132.91M+32.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$13.27M-9.2%
Alkermes logo
AlkermesALKS
$336.7M+83.6%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s inventories?
Innoviva, Inc. (INVA) reported inventories of $38.84M in Q1 2026.
How has Innoviva, Inc.'s inventories changed year-over-year?
Innoviva, Inc.'s inventories decreased by 6.4% year-over-year, from $41.48M to $38.84M.
What is the long-term trend for Innoviva, Inc.'s inventories?
Over 3 years (2022 to 2025), Innoviva, Inc.'s inventories has grown at a 9.9% compound annual growth rate (CAGR), from $126.7M to $168.01M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.